elective surgery
Conditions
Interventions
A:Oral malt dextrin fructose liquid
B: Oral placebo
Sponsors
Tenth People's Hospital of Shanghai
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) General surgery option gastric cancer, colorectal, pancreatic duodenum removal surgery patients; (2) Initial treatment of patients; (3) Inpatients aged 45 to 70 years old men and women; (4) Voluntary signature of written informed consent; (5) Fast for 8-12 hours before surgery and 2 hours for drinking; (6) The length of hospital stay after surgery is greater than 72 hours; (7) The patient does not infuse the sugary solution during the procedure; (8) Digestive physician's participation in preoperative assessment of gastrointestinal function is normal.
Exclusion criteria
Exclusion criteria: (1) Patients who have been diagnosed with diabetes and other severe metabolic diseases; (2) Emergency surgery for patients; (3) Patients with gastric drainage disorder, digestive obstruction, gastroesophageal reflux, inability to use intestinal preparations; (4) Patients with severe cardio-renal insufficiency, etc., affected the safety evaluation of the trial; (5) People with mental disorders, alcohol dependence, and a history of substance abuse; (6) Women who are breastfeeding and pregnant; (7) People who are allergic to a variety of drugs or who have been allergic to a variety of drugs, those who are allergic to malt dextrin fructose; (8) Participants in other clinical studies 3 months prior to the trial; (9) Researchers do not consider it appropriate to be involved in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Glucose;fasting insulin; | — |
Countries
China
Contacts
Public ContactHuanlong Qin
Shanghai Tenth People's Hospital
Outcome results
None listed